I've been buying UVICF pretty heavily as of recently. UVICF makes contact lenses. They made $0.11/share in the quarter reported on Friday and $0.42/share for the TTM. They pay a hefty dividend of $0.09/share/quarter for a yield of almost 10%. They last traded at $3.60 and have been undervalued IMO because of the overhang of 48% of their shares which were held by an entity in liquidation. They are going to buy back those share for $3.15/share pending stockholder approval which IMO is a nobrainer to approve. That buyback is going to significantly increase diluted EPS going forward to something like $0.70/share/year. IMO the stock has a good chance to double in the next six months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.